Bristol-Myers Squibb (BMY) Tops Q1 EPS by 7c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $63.83 -1.27%
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Research and development: 1.14B
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of ($4.40), $0.07 better than the analyst estimate of ($4.47). Revenue for the quarter came in at $11.9 billion versus the consensus estimate of $11.46 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
- Rothschild Redburn Upgrades Apple (AAPL) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
